## **Core Concept**
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired, life-threatening disease of the blood characterized by the destruction of red blood cells (hemolysis), bone marrow failure, and the presence of blood clots (thrombosis). It is caused by a mutation in the PIGA gene of hematopoietic stem cells, leading to a deficiency of glycosylphosphatidylinositol (GPI) anchor on the surface of blood cells. This deficiency makes red blood cells more susceptible to complement-mediated lysis.

## **Why the Correct Answer is Right**
The correct answer, , is associated with PNH because the disease is characterized by the triad of hemolytic anemia, pancytopenia (due to bone marrow failure), and thrombosis. The absence or reduction of GPI-anchored proteins on the surface of blood cells, such as CD55 and CD59, leads to uncontrolled complement activation and subsequent hemolysis. This results in the clinical manifestations of PNH, including hemoglobinuria (often noticed as dark urine), which is a hallmark symptom.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While some forms of anemia can present with similar symptoms, the specific combination of hemolytic anemia, pancytopenia, and thrombosis is highly suggestive of PNH, making other types of anemia less directly related.
- **Option B:** This option does not directly relate to the characteristic clinical or laboratory findings of PNH.
- **Option C:** Similarly, this option does not accurately describe a diagnostic feature or common clinical presentation of PNH.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for PNH is that it often presents with **intravascular hemolysis**, which can lead to **hemoglobinuria**, and patients are at increased risk of **thrombosis**. The diagnosis of PNH can be confirmed by **flow cytometry** demonstrating a deficiency of GPI-anchored proteins on blood cells.

## **Correct Answer:** .